vs
Side-by-side financial comparison of PHOTRONICS INC (PLAB) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PHOTRONICS INC is the larger business by last-quarter revenue ($210.4M vs $164.7M, roughly 1.3× PTC THERAPEUTICS, INC.). PHOTRONICS INC runs the higher net margin — 10.9% vs -82.0%, a 92.8% gap on every dollar of revenue. On growth, PHOTRONICS INC posted the faster year-over-year revenue change (-5.5% vs -22.7%). PHOTRONICS INC produced more free cash flow last quarter ($25.2M vs $-36.6M). Over the past eight quarters, PHOTRONICS INC's revenue compounded faster (-3.8% CAGR vs -11.5%).
Photronics, Inc. is an American semiconductor photomask manufacturer. It was the third largest photomask supplier globally as of 2009. Photronics is a member of the eBeam Initiative.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
PLAB vs PTCT — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $210.4M | $164.7M |
| Net Profit | $22.9M | $-135.0M |
| Gross Margin | 33.7% | — |
| Operating Margin | 22.9% | -43.3% |
| Net Margin | 10.9% | -82.0% |
| Revenue YoY | -5.5% | -22.7% |
| Net Profit YoY | -32.4% | -104.8% |
| EPS (diluted) | $0.39 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $164.7M | ||
| Q3 25 | $210.4M | $211.0M | ||
| Q2 25 | $211.0M | $178.9M | ||
| Q1 25 | $212.1M | $1.2B | ||
| Q4 24 | $222.6M | $213.2M | ||
| Q3 24 | $211.0M | $196.8M | ||
| Q2 24 | $217.0M | $186.7M | ||
| Q1 24 | $216.3M | $210.1M |
| Q4 25 | — | $-135.0M | ||
| Q3 25 | $22.9M | $15.9M | ||
| Q2 25 | $8.9M | $-64.8M | ||
| Q1 25 | $42.9M | $866.6M | ||
| Q4 24 | $33.9M | $-65.9M | ||
| Q3 24 | $34.4M | $-106.7M | ||
| Q2 24 | $36.3M | $-99.2M | ||
| Q1 24 | $26.2M | $-91.6M |
| Q4 25 | — | — | ||
| Q3 25 | 33.7% | — | ||
| Q2 25 | 36.9% | — | ||
| Q1 25 | 35.6% | — | ||
| Q4 24 | 37.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 36.5% | — | ||
| Q1 24 | 36.6% | — |
| Q4 25 | — | -43.3% | ||
| Q3 25 | 22.9% | 1.4% | ||
| Q2 25 | 26.4% | -19.5% | ||
| Q1 25 | 24.6% | 82.5% | ||
| Q4 24 | 25.1% | -76.2% | ||
| Q3 24 | 24.7% | -27.7% | ||
| Q2 24 | 25.8% | -21.5% | ||
| Q1 24 | 26.6% | -21.6% |
| Q4 25 | — | -82.0% | ||
| Q3 25 | 10.9% | 7.5% | ||
| Q2 25 | 4.2% | -36.3% | ||
| Q1 25 | 20.2% | 73.7% | ||
| Q4 24 | 15.2% | -30.9% | ||
| Q3 24 | 16.3% | -54.2% | ||
| Q2 24 | 16.7% | -53.1% | ||
| Q1 24 | 12.1% | -43.6% |
| Q4 25 | — | $-1.63 | ||
| Q3 25 | $0.39 | $0.20 | ||
| Q2 25 | $0.15 | $-0.83 | ||
| Q1 25 | $0.68 | $10.04 | ||
| Q4 24 | $0.54 | $-0.85 | ||
| Q3 24 | $0.55 | $-1.39 | ||
| Q2 24 | $0.58 | $-1.29 | ||
| Q1 24 | $0.42 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $575.8M | $1.9B |
| Total DebtLower is stronger | $16.0K | — |
| Stockholders' EquityBook value | $1.1B | $-205.3M |
| Total Assets | $1.8B | $2.9B |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.9B | ||
| Q3 25 | $575.8M | $1.7B | ||
| Q2 25 | $558.4M | $2.0B | ||
| Q1 25 | $642.2M | $2.0B | ||
| Q4 24 | $640.7M | $1.1B | ||
| Q3 24 | $606.4M | $1.0B | ||
| Q2 24 | $559.9M | $1.1B | ||
| Q1 24 | $521.5M | $884.8M |
| Q4 25 | — | — | ||
| Q3 25 | $16.0K | — | ||
| Q2 25 | $19.0K | — | ||
| Q1 25 | $21.0K | — | ||
| Q4 24 | $25.0K | — | ||
| Q3 24 | $28.0K | — | ||
| Q2 24 | $2.5M | — | ||
| Q1 24 | $2.7M | — |
| Q4 25 | — | $-205.3M | ||
| Q3 25 | $1.1B | $-155.8M | ||
| Q2 25 | $1.1B | $-206.5M | ||
| Q1 25 | $1.1B | $-185.8M | ||
| Q4 24 | $1.1B | $-1.1B | ||
| Q3 24 | $1.1B | $-1.1B | ||
| Q2 24 | $1.0B | $-980.2M | ||
| Q1 24 | $1.0B | $-893.9M |
| Q4 25 | — | $2.9B | ||
| Q3 25 | $1.8B | $2.6B | ||
| Q2 25 | $1.7B | $2.6B | ||
| Q1 25 | $1.7B | $2.7B | ||
| Q4 24 | $1.7B | $1.7B | ||
| Q3 24 | $1.6B | $1.8B | ||
| Q2 24 | $1.6B | $1.9B | ||
| Q1 24 | $1.6B | $1.8B |
| Q4 25 | — | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $50.1M | $-34.3M |
| Free Cash FlowOCF − Capex | $25.2M | $-36.6M |
| FCF MarginFCF / Revenue | 12.0% | -22.3% |
| Capex IntensityCapex / Revenue | 11.8% | 1.4% |
| Cash ConversionOCF / Net Profit | 2.19× | — |
| TTM Free Cash FlowTrailing 4 quarters | $64.5M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-34.3M | ||
| Q3 25 | $50.1M | $-66.3M | ||
| Q2 25 | $31.5M | $-58.3M | ||
| Q1 25 | $78.5M | $870.1M | ||
| Q4 24 | $68.4M | $-30.0M | ||
| Q3 24 | $75.1M | $-77.0M | ||
| Q2 24 | $76.5M | $-71.5M | ||
| Q1 24 | $41.5M | $70.8M |
| Q4 25 | — | $-36.6M | ||
| Q3 25 | $25.2M | $-69.7M | ||
| Q2 25 | $-29.1M | $-59.6M | ||
| Q1 25 | $43.3M | $868.4M | ||
| Q4 24 | $25.2M | $-33.8M | ||
| Q3 24 | $50.7M | $-77.5M | ||
| Q2 24 | $56.5M | $-78.8M | ||
| Q1 24 | $-1.8M | $61.2M |
| Q4 25 | — | -22.3% | ||
| Q3 25 | 12.0% | -33.1% | ||
| Q2 25 | -13.8% | -33.3% | ||
| Q1 25 | 20.4% | 73.8% | ||
| Q4 24 | 11.3% | -15.8% | ||
| Q3 24 | 24.0% | -39.4% | ||
| Q2 24 | 26.0% | -42.2% | ||
| Q1 24 | -0.8% | 29.1% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | 11.8% | 1.6% | ||
| Q2 25 | 28.7% | 0.7% | ||
| Q1 25 | 16.6% | 0.1% | ||
| Q4 24 | 19.4% | 1.8% | ||
| Q3 24 | 11.6% | 0.3% | ||
| Q2 24 | 9.2% | 4.0% | ||
| Q1 24 | 20.0% | 4.6% |
| Q4 25 | — | — | ||
| Q3 25 | 2.19× | -4.17× | ||
| Q2 25 | 3.55× | — | ||
| Q1 25 | 1.83× | 1.00× | ||
| Q4 24 | 2.02× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.11× | — | ||
| Q1 24 | 1.59× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PLAB
| High End Integrated Circuits | $53.6M | 25% |
| High End Flat Panel Displays | $53.5M | 25% |
| KR | $43.7M | 21% |
| Other | $42.1M | 20% |
| Mainstream Flat Panel Displays | $9.1M | 4% |
| Transferred At Point In Time | $8.4M | 4% |
PTCT
Segment breakdown not available.
